# SU5416 and Carboplatin to Treat Ovarian Cancer

> **NCT00006155** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 33 (—)

## Conditions studied

- Fallopian Tube Neoplasm
- Ovarian Cancer
- Peritoneal Neoplasm

## Interventions

- **DRUG:** SU5416 and carboplatin

## Key facts

- **NCT ID:** NCT00006155
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2001-04
- **Target enrollment:** 33 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006155, "SU5416 and Carboplatin to Treat Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*